Jangho Group Co., Ltd. (601886.SS) Bundle
From its founding as Beijing Jangho Curtain Wall Co., Ltd. in 1999 and a strategic rebrand to Jangho Group Co., Ltd. in 2012, this Shanghai-listed firm (601886.SS) has evolved into a dual-focused powerhouse-building façades and medical health-expanding globally with subsidiaries in Saudi Arabia and Dubai in 2024 and winning the 2025 Singapore Institute of Architects Design Award for The Reserve; its bold moves include the 2014 acquisition of Australia's Vision Eye Institute and beginning installation of the Jeddah Tower curtain wall in 2025, while committing to shareholders via a three-year high-dividend plan guaranteeing at least 80% of net income or 0.45 yuan per share annually; financially the company presents a market capitalization of 8.69 billion yuan (as of Dec 16, 2025) with 1.13 billion shares outstanding, trailing and forward P/Es of 13.80 and 13.11, an enterprise value of 8.73 billion yuan, conservative leverage with a debt-to-equity ratio of 0.37, solid liquidity (current ratio 1.19, quick ratio 1.07), and a trailing twelve-month revenue of 21.82 billion yuan with net income of 662.27 million yuan, underpinning a 2024 revenue of 22.41 billion yuan (up 6.93% year-over-year) and analyst expectations for roughly 10% annual revenue growth and 10.2% earnings growth as the company scales curtain-wall design, manufacturing and installation, interior decoration, specialty photovoltaic modules, and ophthalmic hospital services worldwide
Jangho Group Co., Ltd. (601886.SS): Intro
History and corporate evolution- Founded in 1999 as Beijing Jangho Curtain Wall Co., Ltd.; core business originally focused on curtain wall design, manufacture and installation.
- Rebranded to Jangho Group Co., Ltd. in 2012 to reflect a broadened scope beyond curtain walls into façade systems, architectural glass, doors & windows, and integrated building envelopes.
- Strategic diversification in 2014 via acquisition of Vision Eye Institute (Australia's largest ophthalmic care provider), marking an expansion into medical & health services.
- Expanded Middle East footprint in 2024 by establishing subsidiaries in Saudi Arabia and Dubai to service regional construction and façade markets.
- Commenced installation of the first curtain wall unit for Jeddah Tower (Saudi Arabia) in 2025, demonstrating capability on flagship international supertall projects.
- The Reserve project in Singapore (constructed by Jangho) won the 2025 Singapore Institute of Architects Design Award.
- Announced a 2025 three‑year high-dividend plan: distribute at least 80% of net income or 0.45 yuan per share annually (whichever is higher).
- Ticker: 601886.SS (Shanghai Stock Exchange)
- Headquarters: Beijing, China
- Founding year: 1999
- Primary sectors: curtain walls & façades, architectural glass, curtain wall engineering, doors & windows, medical/ophthalmic services (via acquisition)
- Major strategic markets: Greater China, Middle East (Saudi Arabia, UAE), Southeast Asia, Australia
- Project contracting and engineering: end‑to‑end façade solutions (design, manufacture, supply, installation) for commercial towers, hotels, airports and high‑end residential projects - core revenue driver.
- Manufacturing & materials sales: in‑house production of curtain wall modules, specialized glass, aluminium framing and doors - margin capture through vertical integration.
- After‑sales & maintenance: façade maintenance contracts and warranty/retrofit services that provide recurring revenue and long‑tail customer relationships.
- Medical & health services: revenue from Vision Eye Institute and related ophthalmic clinics (patient services, surgeries, optical products) as a diversification pillar.
- International project execution: local subsidiaries and project offices (e.g., Saudi Arabia, Dubai, Singapore) to secure region‑specific contracts and reduce cross‑border execution risk.
| Item | Detail / Value |
|---|---|
| Listing | Shanghai Stock Exchange, 601886.SS |
| Dividend policy (2025 announcement) | Minimum of 80% of net income or 0.45 CNY per share annually (whichever is higher) for three years |
| Major acquisition | 2014 - Vision Eye Institute (Australia) |
| Notable projects | Jeddah Tower (first curtain wall unit installed 2025); The Reserve (Singapore) - 2025 SIA Design Award |
| International subsidiaries | Saudi Arabia, Dubai (established 2024) |
- Project mix: Large signature projects (supertalls, airports, hotels) command premium margins and multi-year revenue recognition; smaller commercial/residential projects provide volume and utilization smoothing.
- Vertical integration: In‑house manufacturing reduces COGS exposure to external suppliers and enables higher gross margin retention on materials-heavy contracts.
- Geographic diversification: Entry into Middle East and Southeast Asia increases exposure to high‑value construction cycles outside China.
- Dividend commitment: High payout target (≥80% NI or 0.45 CNY/share) signals return of cash to shareholders and can materially affect free cash flow allocation toward capex vs distributions.
- Project concentration risk: Large flagship projects (e.g., Jeddah Tower) can distort year‑to‑year revenue and working capital requirements.
- Working capital intensity: Façade engineering and installation require significant upfront manufacturing and on‑site labor, driving receivables and inventory levels.
- Execution risk in overseas markets: Local compliance, logistics and labor management in the Middle East and Southeast Asia require established local operations.
- Policy and construction cycle sensitivity: End-market demand is closely tied to regional construction investment and real estate cycles.
| Metric | Notes / Sample figures |
|---|---|
| Years in operation | Founded 1999 - 25+ years of façade engineering experience |
| Geographic reach | Mainland China, Australia (medical ops), Middle East (Saudi Arabia, UAE), Southeast Asia (Singapore) |
| Business segments | Façades & curtain walls; architectural glass; doors & windows; medical & ophthalmic services |
Jangho Group Co., Ltd. (601886.SS): History
Jangho Group Co., Ltd. was founded as a specialist in exterior decoration and building envelope systems and grew through rapid expansion in China and selective international projects. Key phases include early domestic market consolidation, vertical integration into glass, curtain wall systems and installation services, and a shift toward integrated façade solutions for commercial and large-scale residential developments.- Founded and scaled in China's booming real estate era, focusing on curtain walls, architectural glass and façade systems.
- Expanded capabilities into design, manufacturing and on-site installation to control quality and margin.
- Pursued export and overseas contracting to diversify revenue beyond domestic construction cycles.
| Metric | Value |
|---|---|
| Market Capitalization (Dec 16, 2025) | 8.69 billion CNY |
| Shares Outstanding | 1.13 billion |
| Trailing P/E | 13.80 |
| Forward P/E | 13.11 |
| Enterprise Value | 8.73 billion CNY |
| Debt-to-Equity Ratio | 0.37 |
| Revenue (TTM) | 21.82 billion CNY |
| Net Income (TTM) | 662.27 million CNY |
| Current Ratio | 1.19 |
| Quick Ratio | 1.07 |
| Insider Ownership | 25.58% |
| Institutional Ownership | 8.38% |
- Ownership structure balances significant insider (management/founder) control (25.58%) with external institutional participation (8.38%), leaving the remainder widely held by retail and other investors.
- Conservative leverage (D/E 0.37) and adequate liquidity (current ratio 1.19, quick ratio 1.07) support operational continuity through cyclical construction demand.
- Primary revenue drivers:
- Design and manufacturing of curtain walls, architectural glass and façade systems for commercial and residential complexes.
- Turnkey contracting and on-site installation services-higher-margin integrated projects where Jangho provides end-to-end solutions.
- Aftermarket services and maintenance plus specialty glass products for niche architectural applications.
- How it makes money: vertical integration reduces third-party procurement costs and improves gross margins by capturing manufacturing, design and installation value pools across a project lifecycle.
Jangho Group Co., Ltd. (601886.SS): Ownership Structure
Jangho Group's mission-"working for human's living environment and health"-drives a diversified business model focused on sustainable building systems, medical services (notably ophthalmic care), innovation and social responsibility. The company emphasizes green building solutions and high-quality medical care, while investing in R&D (postdoctoral scientific research workstation) and earning recognition as a national technological innovation demonstration enterprise and one of China's Top 500 Listed Companies and Top 100 Private Enterprises in Beijing. Mission Statement, Vision, & Core Values (2026) of Jangho Group Co., Ltd.- Mission and Values: sustainable urban living, health-focused medical services, innovation, social responsibility, quality and excellence.
- R&D & Recognition: maintains a postdoctoral research workstation; recognized for national-level technological innovation and industry rankings.
- Architectural curtain wall systems and façades: primary revenue driver from design, manufacture and installation for commercial and residential projects.
- Interior decoration and integrated building solutions: turnkey projects, materials supply and installation services.
- Medical and health services: ophthalmology-focused clinics and ancillary medical services generating fee-for-service revenue and health-management contracts.
- After-sales, maintenance and green-building system services: recurring service contracts and sustainability consulting.
| Segment | Primary Activities | Estimated % of Revenue |
|---|---|---|
| Architectural Façades & Curtain Walls | Design, manufacture, installation for buildings | ~60-70% |
| Interior Decoration & Integrated Solutions | Turnkey interiors, materials supply | ~15-20% |
| Medical & Health Services | Ophthalmic clinics, medical treatments | ~5-15% |
| After-sales & Green Building Services | Maintenance, sustainability consulting | ~5-10% |
- Controlling shareholder: founder/holding entities associated with the founding family - majority influence through direct/indirect stakes and related-party holdings.
- Public float: listed A-share float on Shanghai Stock Exchange (ticker 601886.SS) provides liquidity and institutional/public shareholders.
- Management & board alignment: executive ownership and board seats held by founders/major shareholders ensure strategic control.
- Governance highlights: compliance with disclosure rules for listed firms; participation in social responsibility and industry standards.
| Owner Type | Role / Influence | Approx. Stake |
|---|---|---|
| Founding family / controlling holding entities | Strategic control, board influence | ~35-45% |
| Institutional investors (mutual funds, insurers) | Major minority investors, governance oversight | ~20-30% |
| Retail/public shareholders | Liquidity provider, market price formation | ~25-40% |
| State / strategic partners | Project/industry cooperation (if applicable) | ~0-5% |
Jangho Group Co., Ltd. (601886.SS): Mission and Values
How It Works Jangho Group Co., Ltd. (601886.SS) operates through two principal, complementary business sectors-building decoration and medical health-integrating design, manufacturing, and installation to capture value across project lifecycles and service delivery.- Building decoration: end-to-end solutions for façades and interiors, including curtain wall systems, interior decoration and photovoltaic building-integrated applications.
- Medical health: a network of ophthalmology hospitals and clinics delivering surgical and clinical eye-care services (cataract, corneal transplant, retinal surgery) and associated outpatient care.
- Design-to-installation integration: in-house design offices, manufacturing of key façade components, and project management/installation reduce outsourcing and capture margins across the chain.
- Project contracting and recurring services: revenue from one-off engineering & construction projects (curtain walls, façade systems) and recurring/clinical revenue streams from hospital services and follow-up care.
- Geographic diversification: domestic Chinese market plus targeted overseas subsidiaries in the Middle East (Saudi Arabia, Dubai) to access large infrastructure and commercial builds.
- R&D-driven product premiumization: certified state-level technology center supports high-performance systems (energy efficient façades, BIPV) and clinical equipment/process improvements in healthcare units.
- End customers: office buildings, hotels, airports, shopping malls, large public and commercial developments, and individual patients/ophthalmic outpatients.
- Project types: curtain wall systems, unitized façades, glass and aluminum systems, interior fit-out, and building-integrated photovoltaics (BIPV).
- Medical services: outpatient diagnosis, cataract surgeries, corneal transplants, vitreoretinal procedures, and follow-up ophthalmic care.
| Metric | Value / Notes |
|---|---|
| Business segments | Building Decoration; Medical Health (Ophthalmology) |
| Geographic presence | China (core); Subsidiaries/operations in Saudi Arabia and Dubai; projects in MENA, Central Asia, and selected overseas markets |
| R&D | State-recognized technology center; ongoing development in façade systems, energy-efficiency and BIPV |
| Hospital/clinic network | Chain of ophthalmology hospitals and clinics providing surgical and outpatient eye-care services |
| Revenue drivers | Large-scale façade/curtain wall projects; interior decoration contracts; clinical service fees and surgical procedures |
| Typical project scale | From single-building curtain wall contracts (tens to hundreds of millions RMB) to multi-site commercial portfolios and hospital patient volumes |
| Customer focus | Developers, general contractors, government/public works, commercial landlords, individual patients |
- Project contracting margins: delivering integrated façade and interior projects captures gross margin from design, prefabrication and on-site installation.
- Product sales and component manufacturing: sale of specialized façade components, glazing systems, and BIPV modules to contractors and external customers.
- Service and clinical revenues: hospital fees (surgery, outpatient visits, diagnostic services) generate steady cash flow and patient-retention upsell opportunities (follow-up care, corrective procedures).
- After-sales and maintenance: long-term maintenance contracts for façades and facility management services provide recurring income and leverage installed base.
- Integrated value chain-from design and R&D to manufacturing and installation-reduces lead times and improves margin control.
- State-recognized technology center provides product differentiation and supports higher-specification, energy-efficient façade solutions and BIPV integration.
- Overseas subsidiaries (Saudi Arabia, Dubai) enable direct local market access, quicker tender participation, and compliance with regional requirements.
- Dual-industry footprint (construction + healthcare) diversifies cyclicality exposure: construction is project/cycle-driven while medical services provide recurring demand.
| Item | Approximate value (RMB) |
|---|---|
| Annual revenue (group-wide) | Approximately several billion RMB (company annual reports cite multi-billion revenue driven by decoration projects and growing healthcare segment) |
| Net profit | Positive but variable year-to-year due to project mix and one-off items-typically hundreds of millions RMB in profitable years |
| R&D investment | Material investment via technology center; specific annual R&D spend reported in filings (check latest annual report) |
| Backlog and orders | Significant contracted backlog from large curtain wall and interior projects; international tenders contributing to pipeline |
- Customer-centric approach: design and deliver solutions that create measurable value for clients through aesthetics, safety, energy efficiency and lifecycle performance.
- Shareholder and employee value: focus on sustainable growth, technological innovation and human capital development.
- Societal contribution: improving urban living environments via advanced building envelopes and enhancing human health and well-being through ophthalmic services.
Jangho Group Co., Ltd. (601886.SS): How It Works
Jangho Group Co., Ltd. (601886.SS) operates as an integrated façade, interior and specialty-products provider that vertically combines design, manufacturing, sales and on-site installation to capture value across construction cycles. The company's business model monetizes core competencies in engineering, large-scale project execution and diversified service lines to reduce cyclicality and access premium margins on landmark projects. See the company background and broader context here: Jangho Group Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money- Core value chain: design → prefabrication (curtain walls, windows, special façades, PV modules) → logistics → on-site installation → after-sales maintenance.
- Customer segments: commercial developers, airports/transport hubs, hospitality owners, public sector bodies, residential/rental housing and international developers.
- Project type mix: new-build megaprojects, envelope retrofits, interior fit-outs, and specialist energy/medical facility installations.
- Curtain wall systems - design, production and installation for high-rise/commercial projects. Jangho typically captures end-to-end contract fees (engineering & materials margin + installation services) and often negotiates milestone payments tied to project progress.
- Interior decoration & design - turnkey interior fit-outs for hotels, public buildings, apartments and residences; revenues derive from project contracts and value-added design services.
- Special-shaped photovoltaic (PV) modules - manufacturing and sale of architecturally integrated PV units for building-integrated photovoltaics (BIPV) and special façades; recognized as product revenue with growing order pipelines tied to green-building standards.
- Medical services - operation of ophthalmology hospitals and affiliated clinics; revenue from clinical services, diagnostics, surgeries and optical products.
- International subsidiaries & projects - direct subsidiaries and joint ventures (notably in the Middle East: Saudi Arabia, Dubai) enabling local contracting, higher-margin regional projects and diversification of order book.
- After-sales & maintenance - recurring service contracts for façade maintenance, performance guarantees and warranty extensions that create predictable annuity-style cash flows.
| Revenue Stream | Primary Activities | Estimated Contribution (approx.) | Margin Profile |
|---|---|---|---|
| Curtain Wall Systems | Design, manufacture, installation for commercial/transport projects | 60-70% | Gross margin: mid-to-high teens (%) on integrated projects |
| Interior Decoration & Design | Turnkey interior fit-outs for hotels, public buildings, residences | 15-20% | Gross margin: low- to mid-teens (%) depending on project complexity |
| Special-shaped PV Modules | Production and sale of BIPV and shaped photovoltaic elements | 5-10% | Gross margin: variable; improving with scale and proprietary designs |
| Medical Health (Ophthalmology) | Hospital operations, clinical services, optical product sales | 3-6% | Margin: specialty medical services typically generate healthy EBITDA but represent a smaller portion of consolidated revenue |
| International Operations | Local subsidiaries/joint ventures, Middle East projects | 5-10% | Project margins can be higher due to premium contracts and limited local competition |
- Order book & backlog: revenue is driven by a deep, multi-year project backlog. Large curtain-wall contracts generate substantial cashflow during fabrication and installation phases.
- Working capital: manufacturing and project delivery require significant working capital for materials and on-site labor; effective receivables and progress-billing management is critical.
- Vertical integration: owning production facilities (aluminum glazing, glass processing, PV assembly) enhances cost control and shortens lead times, supporting margin stability.
- Technology & premium projects: investment in R&D and high-precision fabrication allows Jangho to bid for complex, award-winning designs (e.g., the Reserve project in Singapore - awarded by the Singapore Institute of Architects, 2025) which command premium pricing.
- Geographic diversification: subsidiaries in Saudi Arabia and Dubai enable access to Gulf construction spending and reduce dependence on domestic cyclical demand.
Jangho Group Co., Ltd. (601886.SS): How It Makes Money
Jangho Group is a leading global provider of high-end façade systems and integrated building solutions. Its core earnings derive from design, manufacture and installation of curtain walls, architectural glass, aluminum systems, and related engineering services, supplemented by downstream businesses in sustainable building solutions and medical health services.- Primary revenue streams: façade systems (curtain walls, curtain wall components), architectural glass, aluminum curtain wall systems, engineering & installation services.
- Adjacencies driving growth: sustainable building solutions (energy-efficient façades, green building materials) and medical health service investments.
- Geographic mix: domestic China projects plus expanding Middle East and Asia‑Pacific contracts to capture global infrastructure demand.
| Metric | Value |
|---|---|
| Market capitalization (as of 16 Dec 2025) | ≈ ¥8.69 billion |
| Revenue (2024) | ¥22.41 billion |
| Revenue growth (2024 vs 2023) | 6.93% |
| Analyst EPS CAGR (forecast) | 10.2% p.a. |
| Analyst Revenue CAGR (forecast) | 10.0% p.a. |
| Shareholder policy | Three‑year high‑dividend plan |
- How cash flows are generated: project contracting (upfront equipment & material sales), engineering & installation milestones, recurring service/maintenance, and margin uplift from proprietary system components.
- Margins and profitability drivers: scale in large façade projects, vertical integration of glass and aluminum production, and premium pricing for high‑end façade solutions.
- Future catalysts: international project wins in the Middle East and Asia‑Pacific, continued adoption of sustainable façades, and contributions from medical health service lines.
Jangho Group Co., Ltd. (601886.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.